Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of 5.24 million. The enterprise value is 5.30 million.
| Market Cap | 5.24M |
| Enterprise Value | 5.30M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Filament Health has 261.79 million shares outstanding. The number of shares has increased by 25.20% in one year.
| Current Share Class | 261.79M |
| Shares Outstanding | 261.79M |
| Shares Change (YoY) | +25.20% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.15% |
| Owned by Institutions (%) | n/a |
| Float | 110.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.26 |
| PB Ratio | 6.68 |
| P/TBV Ratio | 11.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.63 |
| EV / Sales | 15.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.94 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.45 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | -34.90 |
Financial Efficiency
Return on equity (ROE) is -208.81% and return on invested capital (ROIC) is -82.27%.
| Return on Equity (ROE) | -208.81% |
| Return on Assets (ROA) | -52.80% |
| Return on Invested Capital (ROIC) | -82.27% |
| Return on Capital Employed (ROCE) | -240.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8,925 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.31% in the last 52 weeks. The beta is 0.90, so Filament Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -57.31% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 54.53 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Filament Health had revenue of 343,181 and -3.26 million in losses. Loss per share was -0.01.
| Revenue | 343,181 |
| Gross Profit | 343,181 |
| Operating Income | -2.45M |
| Pretax Income | -3.26M |
| Net Income | -3.26M |
| EBITDA | -2.44M |
| EBIT | -2.45M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 498,564 in cash and 349,945 in debt, giving a net cash position of 148,619 or 0.00 per share.
| Cash & Cash Equivalents | 498,564 |
| Total Debt | 349,945 |
| Net Cash | 148,619 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 784,334 |
| Book Value Per Share | 0.00 |
| Working Capital | -724,318 |
Cash Flow
In the last 12 months, operating cash flow was -1.06 million and capital expenditures -10,066, giving a free cash flow of -1.07 million.
| Operating Cash Flow | -1.06M |
| Capital Expenditures | -10,066 |
| Free Cash Flow | -1.07M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -712.94% |
| Pretax Margin | -951.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.20% |
| Shareholder Yield | n/a |
| Earnings Yield | -62.18% |
| FCF Yield | -20.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Filament Health has an Altman Z-Score of -17.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.29 |
| Piotroski F-Score | 1 |